PTH control regimens, by DOPPS country and cross-section

  Oral vitD only IV vitD only Oral+IV vitD only Cinacalcet only Cina+oral vitD Cina+IV vitD Cina+oral&IV vitD None
N Ptnts Wgtd % N Ptnts Wgtd % N Ptnts Wgtd % N Ptnts Wgtd % N Ptnts Wgtd % N Ptnts Wgtd % N Ptnts Wgtd % N Ptnts Wgtd %
DOPPS Country DOPPS Cross-section 2,913 32.7% 761 8.6% 24 0.3% . . . . . . . . 5,202 58.5%
All DOPPS 2(2002)
DOPPS 3(2006) 2,689 31.5% 1,537 17.9% 192 2.3% 196 2.4% 117 1.3% 315 3.7% 25 0.3% 3,460 40.6%
DOPPS 3(2007) 2,549 33.2% 1,286 16.7% 158 2.1% 222 3.0% 153 2.0% 345 4.8% 19 0.3% 2,920 38.0%
AusNZ DOPPS 2(2002) 248 48.4% 4 0.8% . . . . . . . . . . 256 50.7%
DOPPS 3(2006) 264 50.4% . . 6 1.1% 1 0.2% 5 0.9% 1 0.2% . . 250 47.1%
DOPPS 3(2007) 274 54.1% 3 0.8% 14 3.0% 2 0.7% 11 2.3% . . 1 0.1% 180 39.0%
Belgium DOPPS 2(2002) 185 35.3% 1 0.2% . . . . . . . . . . 337 64.5%
DOPPS 3(2006) 213 42.1% 5 1.1% 8 1.6% 6 1.2% 7 1.4% . . 1 0.2% 262 52.5%
DOPPS 3(2007) 203 49.5% 3 0.7% 6 1.4% 7 1.8% 9 2.6% . . . . 184 44.0%
Canada DOPPS 2(2002) 274 45.4% 14 2.4% . . . . . . . . . . 295 52.2%
DOPPS 3(2006) 245 44.2% 24 4.5% 17 3.3% 8 1.4% 6 1.2% 2 0.4% . . 249 45.1%
DOPPS 3(2007) 224 50.8% 17 4.2% 13 2.6% 3 0.6% 12 2.8% 5 1.0% . . 171 38.0%
France DOPPS 2(2002) 183 37.6% 4 0.9% . . . . . . . . . . 303 61.5%
DOPPS 3(2006) 157 28.8% 18 3.4% 3 0.6% 30 5.4% 29 5.2% 6 1.1% 5 0.9% 303 54.7%
DOPPS 3(2007) 164 30.5% 11 2.5% 11 1.8% 55 10.2% 24 4.6% 4 0.9% 5 1.2% 269 48.3%
Germany DOPPS 2(2002) 322 57.5% 8 1.4% 3 0.6% . . . . . . . . 229 40.5%
DOPPS 3(2006) 314 53.5% 14 2.7% 8 1.2% 23 3.6% 41 6.9% 2 0.3% 4 0.6% 175 31.3%
DOPPS 3(2007) 333 52.7% 11 1.5% 17 2.8% 29 4.8% 44 6.8% 7 1.1% 4 0.7% 173 29.6%
Italy DOPPS 2(2002) 164 29.9% 13 2.5% . . . . . . . . . . 367 67.5%
DOPPS 3(2006) 185 35.0% 56 10.6% 23 4.4% 9 1.6% 5 0.9% 8 1.5% . . 245 46.1%
DOPPS 3(2007) 173 31.6% 58 11.5% 12 2.3% 27 4.9% 16 3.0% 11 1.9% 1 0.2% 243 44.6%
Japan DOPPS 2(2002) 811 44.8% 115 6.5% 6 0.4% . . . . . . . . 871 48.4%
DOPPS 3(2006) 710 38.7% 307 16.6% 36 1.9% 2 0.1% . . 1 0.1% . . 775 42.7%
DOPPS 3(2007) 732 39.0% 336 17.8% 30 1.6% . . . . 2 0.1% . . 767 41.5%
Spain DOPPS 2(2002) 129 22.5% 10 1.7% . . . . . . . . . . 441 75.8%
DOPPS 3(2006) 110 16.6% 139 20.6% 12 1.8% 17 2.5% 3 0.4% 31 4.6% 4 0.6% 350 52.8%
DOPPS 3(2007) 40 7.7% 159 27.1% 6 1.4% 29 5.2% 1 0.2% 39 7.0% 2 0.3% 279 51.2%
Sweden DOPPS 2(2002) 282 55.4% 43 8.7% 4 0.7% . . . . . . . . 180 35.2%
DOPPS 3(2006) 240 45.3% 78 14.4% 8 1.3% 9 1.5% 12 1.9% 14 2.7% 2 0.3% 176 32.6%
DOPPS 3(2007) 211 42.6% 67 13.0% 8 1.5% 15 2.9% 26 4.4% 23 4.5% . . 161 31.2%
UK DOPPS 2(2002) 235 43.2% 14 2.5% . . . . . . . . . . 306 54.3%
DOPPS 3(2006) 217 49.3% 4 0.9% 20 4.6% 7 1.7% 6 1.0% . . . . 187 42.5%
DOPPS 3(2007) 179 51.9% 5 1.3% 9 2.7% 8 2.2% 9 2.5% 1 0.3% 1 0.3% 138 38.8%
US DOPPS 2(2002) 80 3.6% 535 23.7% 11 0.5% . . . . . . . . 1,617 72.2%
DOPPS 3(2006) 34 1.9% 892 48.8% 51 3.1% 84 5.2% 3 0.2% 250 13.9% 9 0.5% 488 26.4%
DOPPS 3(2007) 16 1.1% 616 46.3% 32 2.4% 47 3.8% 1 0.1% 253 20.6% 5 0.3% 355 25.3%

Medications reported as prescribed (not necessarily taken) in previous four months, among all patients

Please see additional methodological information in the Data Sources and Methods section.